| 000 | 01341 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250516223357.0 | ||
| 264 | 0 | _c20150511 | |
| 008 | 201505s 0 0 eng d | ||
| 022 | _a1433-2965 | ||
| 024 | 7 |
_a10.1007/s00198-014-2788-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPazianas, M | |
| 245 | 0 | 0 |
_aComment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis. _h[electronic resource] |
| 260 |
_bOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA _cNov 2014 |
||
| 300 |
_a2669 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadverse effects |
| 650 | 0 | 4 |
_aDiphosphonates _xadverse effects |
| 650 | 0 | 4 |
_aGastrointestinal Diseases _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
| 700 | 1 | _aAbrahamsen, B | |
| 773 | 0 |
_tOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA _gvol. 25 _gno. 11 _gp. 2669 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00198-014-2788-0 _zAvailable from publisher's website |
| 999 |
_c24017069 _d24017069 |
||